CASI Pharmaceuticals (CASIF) Q2 2026 Earnings

15MayConfirmed
Q1 1
Q4 2025
Q2 2026
-0.68
-0.57
-0.47
-0.36

Details

Expected EPS
-0.36
Actual EPS
N/A
Surprise EPS
0.36
Surprise Percent
+100%

Description

CASI Pharmaceuticals (CASIF) will report earnings of for Q2 2026 on May 15, 2026.

0 Comments

Share your thoughts